Shaker Nada, Ben Musa Ruwaida, Tynski Zofia, Shaker Nuha, Sangueza Omar P, Boyd Brandon
Department of Pathology and Laboratory Medicine, The Ohio State University Wexner Medical Center, Columbus, USA.
Department of Biomedical Sciences, University of Missouri-Columbia, Columbia, USA.
Int J Surg Pathol. 2025 Apr;33(2):436-441. doi: 10.1177/10668969241260215. Epub 2024 Jun 20.
. SMARCA4-deficient undifferentiated tumors are rare and pose a diagnostic challenge. This study delves into the intricate diagnostic terrain of SMARCA4-deficient undifferentiated tumors, providing insights into their diverse clinical presentations and diagnostic approaches. . A 69-year-old heavy-smoker man with adalimumab-treated rheumatoid arthritis presented with multiple lesions. A CT scan revealed a spiculated lung mass, enlarged mediastinal lymph nodes, and hepatic lesions. A whole-body FDG-PET/CT scan revealed heterogeneous hypermetabolic lesions in the lung, liver, and bone. Initial two core needle liver biopsies and a left upper lobe lung wedge resection initially indicated steatohepatitis and granulomatous formation with no evidence of malignancy. Several months later, the patient returned with left-sided flank pain and significant weight loss. CT scan identified a thigh mass, adrenal lesion, and extensive multiple skeletal lesions. A biopsy of the thigh mass revealed an extensively necrotic, epithelioid-to-spindled cell neoplasm with positive staining for pan keratin, focal staining for CD56, and a loss of nuclear expression of SMARCA4. A final diagnosis of SMARCA4-deficient undifferentiated tumor was rendered. Unfortunately, the patient's condition deteriorated, and he died a few weeks after receiving the final diagnosis. SMARCA4-deficient undifferentiated tumors have emerged as recent subjects of medical study, distinguished by their unique morphology and SMARCA4-deficient immunohistochemistry. These tumors present diverse clinical manifestations, affecting multiple organ systems. This report underscores the diagnostic complexities associated with complex clinical presentation and highlights the importance of multidisciplinary collaboration in addressing challenging clinical scenarios, particularly among heavy smoker male patients and intricate radiological presentations.
SMARCA4缺陷型未分化肿瘤罕见,诊断颇具挑战。本研究深入探讨SMARCA4缺陷型未分化肿瘤复杂的诊断领域,揭示其多样的临床表现及诊断方法。一名69岁重度吸烟男性,患阿达木单抗治疗的类风湿关节炎,出现多处病变。CT扫描显示肺部有毛刺状肿块、纵隔淋巴结肿大及肝脏病变。全身FDG-PET/CT扫描显示肺部、肝脏和骨骼有不均匀的高代谢病变。最初两次肝脏穿刺活检及左上叶肺楔形切除术初步提示为脂肪性肝炎和肉芽肿形成,无恶性证据。数月后,患者因左侧胁腹疼痛和体重显著减轻复诊。CT扫描发现大腿肿块、肾上腺病变及广泛多发的骨骼病变。大腿肿块活检显示为广泛坏死的上皮样至梭形细胞肿瘤,pan角蛋白染色阳性,CD56局灶性染色,SMARCA4核表达缺失。最终诊断为SMARCA4缺陷型未分化肿瘤。不幸的是,患者病情恶化,在确诊数周后死亡。SMARCA4缺陷型未分化肿瘤已成为近期医学研究对象,以其独特形态和SMARCA4缺陷免疫组化特征著称。这些肿瘤临床表现多样,累及多个器官系统。本报告强调了复杂临床表现相关的诊断复杂性,并凸显了多学科协作在应对具有挑战性临床情况中的重要性,尤其是在重度吸烟男性患者及复杂放射学表现的患者中。